Suprastin tab. 25mg # 40
Package quantity, pcs:
twenty
40
Category
Allergy
Scope of the drug
General
Release form
Tablet
Manufacturer country
Hungary
Package quantity, pcs
40
Structure
1 tablet contains 25 mg chloropyramine hydrochloride
excipients: lactose, starch, talc, sodium amylopectin, gelatin, stearic acid.
pharmachologic effect
Suprastin is a histamine H1 receptor blocker, an ethylenediamine derivative.
Prevents the development and facilitates the course of allergic reactions.
It has a moderate sedative and pronounced antipruritic effect.
Possesses peripheral anticholinergic activity, moderate antispasmodic properties.
Indications
Allergic diseases (including urticaria, serum sickness, pollinosis, or hay fever, rhinitis, conjunctivitis)
anaphylactic shock and angioedema
skin diseases (including contact dermatitis, acute and chronic eczema, neurodermatitis, toxicoderma)
prevention and treatment of allergic and pseudoallergic reactions to drugs and diagnostic drugs
itching and insect bites
ARVI.
Contraindications
hypersensitivity to drug components
acute attack of bronchial asthma
children under 3 years of age (for this dosage form)
lactase deficiency, lactose intolerance, glucose / galactose malabsorption (since the tablet contains 116 mg of lactose monohydrate)
pregnancy
lactation period.
With care: angle-closure glaucoma
retention of urine
hyperplasia of the prostate
impaired liver and / or kidney function
cardiovascular diseases
elderly patients.
Side effects
From the side of the central nervous system: lethargy, drowsiness, weakness, slight tremors, dizziness are possible.
In children, some stimulating effect on the central nervous system is possible, manifested by anxiety, increased irritability, and insomnia.
From the digestive system: possible dry mouth, nausea, vomiting, diarrhea or constipation.
From the side of the cardiovascular system: rarely - lowering blood pressure (more often in elderly patients), tachycardia, arrhythmia.
Allergic reactions: possible skin rash, itching.
Others: rarely - difficulty urinating.
Interaction
With the simultaneous use of Suprastin enhances the effects of drugs for anesthesia, hypnotics, tranquilizers, analgesics, MAO inhibitors, tricyclic antidepressants, atropine and sympatholytics.
With the simultaneous use of Suprastin and caffeine or phenamine, there is a decrease or elimination of the inhibitory effect of Suprastin on the central nervous system.
How to take, course of administration and dosage
Adults are prescribed 25 mg (1 tab.) 3-4 times a day (75-100 mg / day).
Children aged 1-12 months are prescribed 1/4 tab.
(6.25 mg) 2-3 times a day (in powder form together with baby food)
2-6 years old - 1/3 tab.
(8.3 mg) 2-3 times a day
7-14 years old - 1/2 tab.
(12.5 mg) 3 times a day.
The tablets should be taken after meals.
Overdose
Treatment:
There are no specific antidotes, so symptomatic treatment is carried out.
In the period up to 12 hours after taking the drug Suprastin, gastric lavage is necessary (it should be borne in mind that the anticholinergic effect of the drug prevents gastric emptying).
The use of activated carbon is also shown.
It is necessary to control the parameters of blood pressure and respiration.
Special instructions
The drug should be used with caution in elderly patients, with liver failure and / or heart disease.
With extreme caution, the drug should be administered orally for angle-closure glaucoma, in patients with urinary retention and prostatic hypertrophy.
When taken at night, the drug may worsen the symptoms of reflux esophagitis.
With caution, Suprastin should be prescribed simultaneously with sedatives, tranquilizers, analgesics, MAO inhibitors, tricyclic antidepressants, atropine and / or sympatholytics.
During treatment, you should exclude the use of alcoholic beverages.
Impact on the ability to drive a car
Name ENG
SUPRASTIN
Clinical and pharmacological group
Blocker of histamine H1 receptors.
Antiallergic drug
ATX code
Chloropyramine
Dosage
25mg
Structure
1 tablet contains 25 mg chloropyramine hydrochloride
excipients: lactose, starch, talc, sodium amylopectin, gelatin, stearic acid.
Indications
Allergic diseases (including urticaria, serum sickness, pollinosis, or hay fever, rhinitis, conjunctivitis)
anaphylactic shock and angioedema
skin diseases (including contact dermatitis, acute and chronic eczema, neurodermatitis, toxicoderma)
prevention and treatment of allergic and pseudoallergic reactions to drugs and diagnostic drugs
itching and insect bites
ARVI.
Contraindications
Hypersensitivity to drug components
acute attack of bronchial asthma
children under 3 years of age (for this dosage form)
lactase deficiency, lactose intolerance, glucose / galactose malabsorption (since the tablet contains 116 mg of lactose monohydrate)
pregnancy
lactation period.
With care: angle-closure glaucoma
retention of urine
hyperplasia of the prostate
impaired liver and / or kidney function
cardiovascular diseases
elderly patients.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 5 years
INN / Active ingredient
Chloropyramine
Specifications
Category
Allergy
Scope of the drug
General
Release form
Tablet
Manufacturer country
Hungary
Package quantity, pcs
40
Minimum age from
1 month
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Egis
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
R06AC03 Chloropyramine
Dosage form
Pills
Dosage (volume) of the substance in the preparation
25 mg
Expiration date in days
1825
The target audience
Children
Package weight, g
thirty
Mode of application
:
Adults are prescribed 25 mg (1 tab.) 3-4 times a day (75-100 mg / day).
Children aged 1-12 months are prescribed 1/4 tab.
(6.25 mg) 2-3 times a day (in powder form together with baby food)
2-6 years old - 1/3 tab.
(8.3 mg) 2-3 times a day
7-14 years old - 1/2 tab.
(12.5 mg) 3 times a day.
Pharmaco-therapeutic group
:
Antiallergic agent - H1-histamine receptor blocker
Information on technical characteristics, delivery set, country of manufacture